ArticleProbiotics and antimicrobial proteins2026
Dual Effects of a Bothrops asper Phospholipase A₂: Anti-Vibrio Properties and Shrimp Hemocyte Cytotoxicity.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Emerging antibiotic-resistant Vibrio spp. strains have caused recurrent outbreaks, resulting in substantial losses in shrimp farming and aquaculture production. This ongoing crisis calls for innovative strategies to mitigate its impact, particularly in resource-limited countries that depend heavily on the shrimp industry. In this context, biodiscovery initiatives focused on snake venom toxins with antimicrobial properties represent a promising alternative. Accordingly, we investigated the anti-Vibrio activity of a catalytically inactive phospholipase A₂ (Lys49 PLA₂) purified from the venom of Bothrops asper, a venomous snake commonly found in Ecuador. This novel bioactive biomacromolecule, termed BaETx, was isolated from a venom pool using a one-step purification approach. Mass spectrometry analysis revealed a molecular mass of 13.6 kDa, consistent with its electrophoretic mobility in one-dimensional SDS-PAGE. Structurally, BaETx exhibits high similarity to the amino acid sequences of PLA₂s previously reported from B. asper venoms in other geographical regions. Bioactivity screening demonstrated that BaETx significantly inhibited the in vitro growth of three Gram-negative Vibrio spp. pathogens. Further mechanistic insights obtained through electron and fluorescence microscopy suggest a membrane-damaging actitvity. However, BaETx also significantly reduced shrimp hemocyte viability, indicating non-selective action and limiting its direct application in aquaculture. In addition, computational sequence analysis identified cationic antimicrobial fragments that warrant further investigation. Overall, this study reports the first purification and characterization of an antimicrobial protein from Ecuadorian snake venom, highlighting its potential as a molecular template for the development of shorter and more selective synthetic peptides targeting white shrimp pathogens.
Indexed as
Identifiers
42377779What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.